NCT03454932View on ClinicalTrials.gov

Research Study on the Immunosuppressive Effects of a Cell Therapy Product on PBMC Isolated From Blood of Patients With Inflammatory Rheumatic Diseases

TerminatedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

April 30, 2017

Study Completion Date

June 4, 2017

Conditions
Rheumatoid ArthritisPsoriatic ArthritisSpondylarthritis
Interventions
OTHER

Blood sampling

Sponsors
All Listed Sponsors
lead

Bone Therapeutics S.A

INDUSTRY

NCT03454932 - Research Study on the Immunosuppressive Effects of a Cell Therapy Product on PBMC Isolated From Blood of Patients With Inflammatory Rheumatic Diseases | Biotech Hunter | Biotech Hunter